Demo Sign up Log In

Ligand Pharmaceuticals Inc (LGND)

Total Costs & Expenses

$189.61M

TTM · Period ending: Jun 30, 2026 · USD

LGND Total Costs & Expenses

Latest reported$189.61Mperiod endingJun 30, 2026

Latest reported$189.61Mperiod endingJun 30, 2026

LGND TTM Total Costs & Expenses ($34.20M → $189.61M)

TTM Total Costs & Expenses

High-resolution chart · PNG

LGND total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2001	97,828,000
Mar 31, 2001	97,022,000
Dec 31, 2000	93,991,000
Sep 30, 2000	94,845,000
Jun 30, 2000	95,718,000
Mar 31, 2000	96,570,000
Dec 31, 1999	97,200,000
Sep 30, 1999	101,300,000
Jun 30, 1999	97,200,000
Mar 31, 1999	92,600,000
Dec 31, 1998	87,300,000
Sep 30, 1998	82,800,000
Jun 30, 1998	82,500,000
Mar 31, 1998	81,200,000
Dec 31, 1997	82,400,000
Sep 30, 1997	78,900,000
Jun 30, 1997	75,500,000
Mar 31, 1997	73,600,000
Dec 31, 1996	69,600,000
Sep 30, 1996	64,700,000
Jun 30, 1996	61,900,000
Mar 31, 1996	44,500,000
Dec 31, 1995	38,300,000
Sep 30, 1995	32,600,000
Jun 30, 1995	26,800,000
Mar 31, 1995	35,000,000
Dec 31, 1994	34,200,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.